Immediate Impact
34 standout
Citing Papers
Ethical and regulatory considerations in the use of AI and machine learning in nursing: A systematic review
2025 Standout
Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
Works of Martina Murphy being referenced
Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.
2022
Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Martina Murphy | 73 | 71 | 41 | 71 | 49 | 346 | |
| Eric D. Tetzlaff | 121 | 74 | 96 | 13 | 37 | 383 | |
| Gregory M. Gressel | 72 | 66 | 30 | 24 | 47 | 329 | |
| Ankita Kapoor | 57 | 30 | 12 | 19 | 32 | 342 | |
| Michael M. Wach | 124 | 41 | 6 | 54 | 33 | 368 | |
| Olamide Alabi | 38 | 38 | 43 | 10 | 40 | 341 | |
| Kartik Shenoy | 23 | 73 | 52 | 41 | 31 | 340 | |
| Marlene Girardo | 19 | 43 | 38 | 41 | 52 | 313 | |
| Joseph A. Mellia | 21 | 104 | 22 | 109 | 38 | 333 | |
| Rola Khamisy‐Farah | 72 | 38 | 13 | 18 | 35 | 377 | |
| Jason C. Hoffmann | 29 | 96 | 44 | 99 | 36 | 398 |
All Works
Loading papers...